{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T05:21:30Z","timestamp":1781932890212,"version":"3.54.5"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.pharma.2023.09.001","type":"journal-article","created":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T20:00:18Z","timestamp":1694548818000},"page":"985-996","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Nose-to-brain delivery of hesperidin nanoparticles loaded in-situ gel for neuroprotective action"],"prefix":"10.1016","volume":"81","author":[{"given":"Suraj","family":"Bamankar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3718-9858","authenticated-orcid":false,"given":"Vaishali","family":"Londhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharma.2023.09.001_bib0150","unstructured":"World Health Organization. Depression [Internet]. [cited 2022 Dec 29], https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/depression."},{"issue":"7","key":"10.1016\/j.pharma.2023.09.001_bib0155","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.drudis.2020.05.001","article-title":"Role of oxidative stress in depression","volume":"25","author":"Bhatt","year":"2020","journal-title":"Drug Discov Today"},{"issue":"1","key":"10.1016\/j.pharma.2023.09.001_bib0160","doi-asserted-by":"crossref","first-page":"307","DOI":"10.5958\/0974-360X.2017.00062.2","article-title":"Effect of hesperidin for its anti-proliferative activity on liver cancer and cardio vascular diseases","volume":"10","author":"Julius","year":"2017","journal-title":"Res J Pharm Technol"},{"issue":"2","key":"10.1016\/j.pharma.2023.09.001_bib0165","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3390\/antiox10020328","article-title":"Polyphenols in the Mediterranean diet: from dietary sources to microRNA modulation","volume":"10","author":"Cannataro","year":"2021","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.pharma.2023.09.001_bib0170","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1423-0127-18-84","article-title":"Hesperetin-7,3\u2019-O-dimethylether selectively inhibits phosphodiesterase 4 and effectively suppresses ovalbumin-induced airway hyperresponsiveness with a high therapeutic ratio","volume":"18","author":"Yang","year":"2011","journal-title":"J Biomed Sci"},{"issue":"1","key":"10.1016\/j.pharma.2023.09.001_bib0175","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1046\/j.1471-4159.2003.01652.x","article-title":"Interaction between flavonoids and the blood-brain barrier: in vitro studies","volume":"85","author":"Youdim","year":"2003","journal-title":"J Neurochem"},{"issue":"5","key":"10.1016\/j.pharma.2023.09.001_bib0180","first-page":"505","article-title":"The pharmacological potential of hesperidin","volume":"57","author":"Ganeshpurkar","year":"2020","journal-title":"Indian J Biochem Biophys"},{"issue":"1","key":"10.1016\/j.pharma.2023.09.001_bib0185","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0009-9236(96)90164-2","article-title":"Flavanone absorption after naringin, hesperidin, and citrus administration","volume":"60","author":"Ameer","year":"1996","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.pharma.2023.09.001_bib0190","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s11095-008-9729-6","article-title":"Solubility, stability, physicochemical characteristics and in vitro ocular tissue permeability of hesperidin: A natural bioflavonoid","volume":"26","author":"Majumdar","year":"2009","journal-title":"Pharm Res"},{"issue":"23","key":"10.1016\/j.pharma.2023.09.001_bib0195","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.3390\/molecules24234246","article-title":"Phytofabrication of nanoparticles as novel drugs for anticancer applications","volume":"24","author":"Wei","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.pharma.2023.09.001_bib0200","doi-asserted-by":"crossref","first-page":"101631","DOI":"10.1016\/j.apmt.2022.101631","article-title":"On a highway to the brain: A review on nose-to-brain drug delivery using nanoparticles","volume":"29","author":"Formica","year":"2022","journal-title":"Appl Mater Today"},{"issue":"4","key":"10.1016\/j.pharma.2023.09.001_bib0205","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1080\/03639045.2020.1747485","article-title":"Sonication tailored enhance cytotoxicity of naringenin nanoparticle in pancreatic cancer: design, optimization, and in\u00a0vitro studies","volume":"46","author":"Akhter","year":"2020","journal-title":"Drug Dev Ind Pharm"},{"issue":"1","key":"10.1016\/j.pharma.2023.09.001_bib0210","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1080\/21691401.2018.1559175","article-title":"Fabrication of hesperidin nanoparticles loaded by poly lactic co-glycolic acid for improved therapeutic efficiency and cytotoxicity","volume":"47","author":"Ali","year":"2019","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"January","key":"10.1016\/j.pharma.2023.09.001_bib0215","first-page":"1","article-title":"Nasal delivery of hesperidin\/chitosan nanoparticles suppresses cytokine storm syndrome in a mouse model of acute lung injury","volume":"11","author":"Jin","year":"2021","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.pharma.2023.09.001_bib0220","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.nano.2008.12.003","article-title":"PLGA nanoparticle formulations of risperidone: preparation and neuropharmacological evaluation","volume":"5","author":"Muthu","year":"2009","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"10.1016\/j.pharma.2023.09.001_bib0225","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jddst.2015.08.003","article-title":"Formulation and evaluation of thermoreversible mucoadhesive in-situ gel for intranasal delivery of naratriptan hydrochloride","volume":"29","author":"Shelke","year":"2015","journal-title":"J Drug Deliv Sci Technol"},{"issue":"2","key":"10.1016\/j.pharma.2023.09.001_bib0230","first-page":"327","article-title":"Behavioral despair in mice: A primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch Int Pharmacodyn Ther"},{"issue":"2","key":"10.1016\/j.pharma.2023.09.001_bib0235","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s12640-019-00098-8","article-title":"Cerebroprotective potential of hesperidin nanoparticles against bilateral common carotid artery occlusion reperfusion injury in rats and in silico approaches","volume":"37","author":"Praveen Kumar","year":"2020","journal-title":"Neurotox Res"},{"issue":"3","key":"10.1016\/j.pharma.2023.09.001_bib0240","doi-asserted-by":"crossref","DOI":"10.1088\/2043-6262\/5\/3\/035013","article-title":"A new formulation of curcumin using poly (lactic-co-glycolic acid) - Polyethylene glycol diblock copolymer as carrier material","volume":"5","author":"Tuyen Dao","year":"2014","journal-title":"Adv Nat Sci Nanosci Nanotechnol"},{"issue":"8","key":"10.1016\/j.pharma.2023.09.001_bib0245","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1023\/B:PHAM.0000036917.75634.be","article-title":"Physicochemical parameters associated with nanoparticle formation in the salting-out, emulsification-diffusion, and nanoprecipitation methods","volume":"21","author":"Galindo-Rodriguez","year":"2004","journal-title":"Pharm Res"},{"issue":"1","key":"10.1016\/j.pharma.2023.09.001_bib0250","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejps.2004.09.011","article-title":"Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles","volume":"24","author":"Bilati","year":"2005","journal-title":"Eur J Pharm Sci"},{"issue":"10","key":"10.1016\/j.pharma.2023.09.001_bib0255","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3390\/pharmaceutics11100514","article-title":"Effect of size and concentration of PLGA-PEG nanoparticles on activation and aggregation of washed human platelets","volume":"11","author":"Bakhaidar","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.pharma.2023.09.001_bib0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/1743765","article-title":"Encapsulation of nicardipine hydrochloride and release from biodegradable poly(D,L-lactic-co-glycolic acid) microparticles by double emulsion process: effect of emulsion stability and different parameters on drug entrapment","volume":"2017","author":"Soomherun","year":"2017","journal-title":"Int J Biomater"},{"issue":"1","key":"10.1016\/j.pharma.2023.09.001_bib0265","doi-asserted-by":"crossref","first-page":"23345","DOI":"10.1038\/s41598-021-02826-7","article-title":"Optimization of entrapment efficiency and release of clindamycin in microsponge based gel","volume":"11","author":"Khattab","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.pharma.2023.09.001_bib0270","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2174\/1574885514666190226155933","article-title":"Formulation and in vitro evaluation of hesperidin-phospholipid complex and its antioxidant potential","volume":"15","author":"Kalita","year":"2019","journal-title":"Curr Drug Ther"},{"issue":"3","key":"10.1016\/j.pharma.2023.09.001_bib0275","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3390\/jfb13030109","article-title":"PLGA nanoparticles uptake in stem cells from human exfoliated deciduous teeth and oral keratinocyte stem cells","volume":"13","author":"Tizu","year":"2022","journal-title":"J Funct Biomater"},{"issue":"8","key":"10.1016\/j.pharma.2023.09.001_bib0280","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1021\/acs.molpharmaceut.1c00366","article-title":"Structure and fate of nanoparticles designed for the nasal delivery of poorly soluble drugs","volume":"18","author":"Clementino","year":"2021","journal-title":"Mol Pharm"},{"issue":"1","key":"10.1016\/j.pharma.2023.09.001_bib0285","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s40005-022-00589-5","article-title":"Drug delivery to the brain via the nasal route of administration: exploration of key targets and major consideration factors","volume":"53","author":"Jeong","year":"2022","journal-title":"J Pharm Investig"},{"issue":"2","key":"10.1016\/j.pharma.2023.09.001_bib0290","first-page":"63","article-title":"Nasal delivery - A promising route of drug delivery to the brain: Scientific considerations","volume":"18","author":"Pathak","year":"2018","journal-title":"Drug Dev Deliv"}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450923001049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450923001049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T23:37:36Z","timestamp":1757720256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003450923001049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0003450923001049"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2023.09.001","relation":{},"ISSN":["0003-4509"],"issn-type":[{"value":"0003-4509","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nose-to-brain delivery of hesperidin nanoparticles loaded in-situ gel for neuroprotective action","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2023.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Acad\u00e9mie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}